Ocular manifestations in psoriasis of Iraqi patients

Authors

  • Ahmed Abdulhussein Kawen Department of Dermatology, College of Medicine, University of Thi-Qar, Thi-Qar, Iraq
  • Muataz Hasan Jaaz Department of Surgery, College of Medicine, University of Thi-Qar, Thi-Qar, Iraq

Keywords:

Ocular, Psoriasis, HLA

Abstract

Objective A cross-sectional study was established in Iraq Dhi Qar Governorate, which aimed to determine the prevalence of ocular manifestations in psoriasis among Iraqi patients.   Methods This study was designed according to the frequency of ocular manifestations in psoriasis in Iraq, where reliance was placed on the statistical analysis program SPSS and the Schirmer test. To semiquantitative test of tear production that measures the physical tendency of a fluid to travel along a strip of porous material by capillary action due to surface tension for the diagnosis of dry eye. The statistical analysis program SPSS was relied on to analyse demographic data and information about patients.   Results/Conclusion The statistical analysis program SPSS was relied on to analyse demographic data and information about patients. The mean age of the patients was 45.2±13.5, and results were found with a statistical correlation between ocular diseases in patients, where a high percentage of contract was found for 50 patients and 100 eyes. In addition, other abnormalities in the eye were found, including keratitis and blepharitis. Moreover, the presence of eye diseases affects the degree of disease activity and the cutaneous form of psoriasis. It can affect one or both eyes, as it generally appears with outbreaks of infections that recur over time. About half of uveitis is due to an unknown cause.  

References

Balato N., Napolitano M., Ayala F., Patruno C., Megna M., Tarantino G. Nonalcoholic fatty liver disease, spleen, and psoriasis: New aspects of low-grade chronic inflammation. World J. Gastroenterol. 2015; 21:6892–6897. Doi: 10.3748/wjg. v21.i22.6892. [PMC free article]

Ruggiero A., Fabbrocini G., Cinelli E., Megna M. Efficacy and safety of guselkumab in psoriasis patients who failed usteki-numab and/or anti-interleukin-17 treatment: A real-life 52-week retrospective study. Dermatol. Ther. 2020; 13:4673. [PubMed] [Google Scholar]

Oliveira M.d.F., Rocha B.d.O., Duarte G.V. Psoriasis: Classical and emerging comorbidities. An. Bras. Dermatol. 2015; 90:9–20. doi: 10.1590/abd1806-4841.20153038. [PMC free article]

Demerdjieva Z., Mazhdrakova I., Tsankov N. Ocular changes in patients with psoriasis. Clin. Dermatol. 2019; 37:663–667. Doi: 10.1016/j.clindermatol.2019.07.029.

Chimenti M.S., Triggianese P., Salandri G., Conigliaro P., Canofari C., Caso F., Costa L., Nucci C., Aiello F., Cesareo M., et al. A Multimodal Eye Assessment in Psoriatic Arthritis Patients Sine-Psoriasis: Evidence for a Potential Association with Systemic Inflammation. J. Clin. Med. 2020; 9:719. doi: 10.3390/jcm9030719. [PMC free article]

Lam M., Steen J., Lu J.D., Vender R. The Incidence and Prevalence of Uveitis in Psoriasis: A Systematic Review and Me-ta-Analysis. J. Cutan. Med. Surg. 2020; 24:601–607. doi: 10.1177/1203475420952420.

Murray P.I., Rauz S. The eye and inflammatory rheumatic diseases: The eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis. Best Pr. Res. Clin. Rheumatol. 2016; 30:802–825. doi: 10.1016/j.berh.2016.10.007.

Abbouda A., Abicca I., Fabiani C., Scappatura N., García P.P., Scrivo R., Priori R., Paroli M.P. Psoriasis and Psoriatic Ar-thritis-Related Uveitis: Different Ophthalmological Manifestations and Ocular Inflammation Features. Semin. Ophthalmol. 2017; 32:715–720. doi: 10.3109/08820538.2016.1170161.

Van de Kerkhof P.C., Murphy G.M., Austad J., Ljungberg A., Cambazard F., Duvold L.B. Psoriasis of the face and flexures. J. Dermatol. Treat. 2007; 18:351–360. doi: 10.1080/09546630701341949.

Ghalamkarpour F., Baradaran-Rafii A., Sadoughi M.M., Abdollahimajd F., Younespour S., Zargari O., Rudolph R.I. Ocular findings in patients with psoriasis: Is it related to the side effects of treatment or to psoriasis itself? A case-control study. J. Dermatol. Treat. 2019; 31:27–32. doi: 10.1080/09546634.2019.1577947.

Kilic B., Dogan U., Parlak A.H., Goksugur N., Polat M., Serin D., Ozmen S. Ocular findings in patients with psoriasis. Int. J. Dermatol. 2013; 52:554–559. doi: 10.1111/j.1365-4632.2011.05424. x.

Rehal B., Modjtahedi B.S., Morse L.S., Schwab I.R., Maibach H.I. Ocular psoriasis. J. Am. Acad. Dermatol. 2011; 65:1202–1212. doi: 10.1016/j.jaad.2010.10.032.

Balato A., Di Costanzo L., Patruno C., Ayala F., Megna M., Balato N. Psoriasis or “psoriases”? G. Ital. Dermatol. Venereol. 2013; 148:649–650. [PubMed] [Google Scholar]

Bernhard J.D., Kumar B., Sharma V.K. Is Eyelid Involvement a Sign of Severe Psoriasis? /Papulonecrotic Tuberculides on Glans penis? Dermatology. 1987; 174:151–152. doi: 10.1159/000249009.

Cruz N.F.S.D., Brandão L.S., Cruz S.F.S.D., Cruz S.A.S.D., Pires C.A.A., Carneiro F.R.O. Ocular manifestations of psoriasis. Arq. Bras. Oftalmol. 2018; 81:219–225. doi: 10.5935/0004-2749.20180044.

Downloads

Published

2024-04-21

How to Cite

1.
Kawen AA, Jaaz MH. Ocular manifestations in psoriasis of Iraqi patients. J Pak Assoc Dermatol [Internet]. 2024Apr.21 [cited 2024May22];34(2):453-7. Available from: https://jpad.com.pk/index.php/jpad/article/view/2694

Issue

Section

Original Articles